Search results for "Prostaglandins E"

showing 5 items of 5 documents

Effects of cimetidine, atropine and prostaglandin E2 on rat mucosal erosions produced by intragastric distension

1980

Abstract The effects of three typical antisecretory agents: cimetidine, atrophine and prostaglandin E2 were compared on an acute rat gastric ulcer model which consisted of perfusing the stomach continuously, at a high intraluminal pressure (120 mm H2O), with a simulated gastric juice (0.1 M HCl plus 600 mg pepsin/1). As the acid and pepsin are given exogenously the inhibitory action of the antisecretory drugs is obviated in this model. Cimetidine and atropine failed to reduce gastric erosions, whereas prostaglandin E2 markedly reduced the severity of the mucosal lesions with respect to control values. Long-term treatment with cimetidine also failed to increase the resistance of the gastric …

AtropineMalemedicine.medical_treatmentPharmacologyGuanidinesPepsinmedicineGastric mucosaAnimalsStomach UlcerProstaglandin E2CimetidinePharmacologyGastric Juicebiologybusiness.industryProstaglandins EGastric distensionStomachdigestive oral and skin physiologyRatsDisease Models AnimalAtropinemedicine.anatomical_structureAnesthesiabiology.proteinmedicine.symptomCimetidinebusinessProstaglandin Emedicine.drugEuropean Journal of Pharmacology
researchProduct

The specificity of prostaglandin E2 (PGE2) in reducing coronary vascular resistance: A comparison with adenosine.

1978

Experiments were performed on the isolated, electrically driven guinea-pig heart, perfused at constant rate. All animals were pretreated with reserpine. Myocardial contractile force (MCF), coronary perfusion pressure (CPP) and myocardial oxygen consumption (QO2) were monitored continuously. Both adenosine (ADO) and PGE2 produced a concentration-dependent decrease in the CPP. The ED50 (50% of maximum response) was 2.1 +/- 0.6 X 10(-9)M for PGE2 but 40 +/- 7 X 10(-9)M for ADO (P less than 0.01) at 1.8 mM Ca(e). This coronary vasodilation was independent of the external Ca-concentration, which was varied between 0.55-9.0 mM. PGE2 had no effect on MCF or QO2 and the effect of ADO was only sligh…

Malemedicine.medical_specialtyAdenosinePhysiologyGuinea Pigschemistry.chemical_elementProstaglandinBlood PressureOxygenchemistry.chemical_compoundOxygen ConsumptionPhysiology (medical)Internal medicinemedicineAnimalsProstaglandin E2Prostaglandins EReserpineAdenosineCoronary VesselsPerfusionConstant ratemedicine.anatomical_structurechemistryCardiologyCoronary perfusion pressureVascular resistanceFemaleVascular ResistanceCardiology and Cardiovascular Medicinemedicine.drugBasic research in cardiology
researchProduct

ACTIONS OF PROSTAGLANDIN E2 ON MYOCARDIAL MECHANICS, CORONARY VASCULAR RESISTANCE AND OXYGEN CONSUMPTION IN THE GUINEA-PIG ISOLATED HEART PREPARATION

1975

Abstract 1 In isolated, electrically driven (3 Hz) hearts of guinea-pigs the action of prostaglandin E2 on left ventricular pressure (LVP), oxygen consumption (Qo2) and coronary vascular resistance (CVR) was studied by establishing cumulative concentration-response curves. The hearts were perfused at a constant flow (10 ml/min) with Tyrode solution (Ca++ 1.8 mM) at 32 degrees C. 2 Under control conditions prostaglandin E2 (2.86 X10(-11) -1.43 X 10(-7) M) decreased LVP, QO2 and CVR in a concentration-dependent manner by maximally 27, 18 and 38%, respectively (P less than 0.05). 3 After reserpine pretreatment there were lower initial values for all parameters measured. The effect of prostagla…

Malemedicine.medical_specialtyReserpineTime Factorsmedicine.medical_treatmentGuinea PigsBlood PressureIn Vitro TechniquesCoronary circulationOxygen ConsumptionHeart RateCoronary CirculationInternal medicineHeart ratemedicineAnimalsProstaglandin E2Pharmacologybusiness.industryProstaglandins EHeartReserpineMyocardial Contractionmedicine.anatomical_structureEndocrinologyBlood pressureVascular resistanceVentricular pressureFemaleVascular ResistancebusinessResearch Articlemedicine.drugProstaglandin EBritish Journal of Pharmacology
researchProduct

INTERACTIONS OF ISOPRENALINE AND PROSTAGLANDIN E2 WITH RESPECT TO MYOCARDIAL CONTRACTILE FORCE, CORONARY VASCULAR RESISTANCE AND MYOCARDIAL OXYGEN CO…

1976

Left ventricular pressure (LVP), left ventricular pressure derivative (LV dp/dtmax), coronary vascular resistance (CVR) and myocardial oxygen consumption (Qo2) were measured simultaneously in isolated, electrically driven hearts of guinea-pigs at constant perfusion rate. 2 LVP, LV dp/dtmax, CVR and Qo2 were greatly decreased by either the addition of prostaglandin E2 (50 ng/ml) to the perfusion fluid or pretreatment of the animals with reserpine. 3 Isoprenaline (0.5 nM to 100 nM) induced increases in LVP, LV dp/dtmax and Qo2. In the presence of prostaglandin E2, there was a parallel shift of the isoprenaline concentration-response curve for LVP and LV dp/dtmax. This effect was not seen, aft…

Malemedicine.medical_specialtyReserpinemedicine.medical_treatmentGuinea PigsIndomethacinProstaglandinBlood PressureNorepinephrinechemistry.chemical_compoundOxygen ConsumptionInternal medicineIsoprenalinemedicineAnimalsDrug InteractionsProstaglandin E2PharmacologyDose-Response Relationship Drugbusiness.industryMyocardiumProstaglandins EIsoproterenolReserpineCoronary VesselsMyocardial ContractionBlood pressuremedicine.anatomical_structurechemistryCardiologyVentricular pressureVascular resistanceFemaleVascular ResistancebusinessResearch Articlemedicine.drugProstaglandin EBritish Journal of Pharmacology
researchProduct

Prostaglandin production by human polymorphnuclear leucocytes during phagocytosis in vitro.

1977

Human polymorphonuclear leukocytes were found to be able to synthetize and release substantial amounts of PGE2' when stimulated by a phagocytic stimulus such as zymosan particles coated with complement. Hydrocortisone, at a concentration of 10(-5) M, which proved to be effective in other biological systems, failed to inhibit phagocytosis and PG release.

PharmacologyPolymorphonuclear leukocyteNeutrophilsPhagocytosismedicine.medical_treatmentProstaglandins EZymosanProstaglandin productionZymosanProstaglandinCell BiologyIn Vitro TechniquesIn vitroMicrobiologyCellular and Molecular Neurosciencechemistry.chemical_compoundchemistryPhagocytosisImmunologymedicineMolecular MedicineHumansMolecular BiologyProstaglandin EExperientia
researchProduct